(Q35132006)

6 August 2017

1 reference

title

Can we control tuberculosis in high HIV prevalence settings? (English)

1 reference

6 August 2017

0 references

Helen Ayles

2

0 references

Peter Godfrey-Faussett

series ordinal

1

object named as

Peter Godfrey-Faussett

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

83

1 reference

6 August 2017

1-3

1 reference

6 August 2017

68-76

1 reference

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis and HIV infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of c

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis in Africa: clinical presentation and management

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African Hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Reduced sensitivity of tuberculosis serodiagnosis in patients with AIDS in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Transmission of tuberculosis in British centre for patients infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

High death rates in health care workers and teachers in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis in disadvantaged groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Staff and patient attitudes to tuberculosis and compliance with treatment: an exploratory study in a district in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Social scientists and the new tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis and the poverty-disease cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Mycobacteriosis and HIV infection: the new public health challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Economic barriers for tuberculosis patients in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

A second study of the use of community leaders in case-finding for pulmonary tuberculosis in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

A third study of case-finding methods for pulmonary tuberculosis in kenya, including the use of community leaders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

A fourth study of case-finding methods for pulmonary tuberculosis in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis control and molecular epidemiology in a South African gold-mining community

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

A longitudinal study of transmission of tuberculosis in a large prison population

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Transmission of tuberculosis to contacts of sputum positive adults in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Giving medicine a fair trial. It needs to be established whether patients really fare better in trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Improving the health of the global poor

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

Declining HIV prevalence and risk behaviours in Zambia: evidence from surveillance and population-based surveys

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2802%2900083-5

7 January 2021

10.1016/S1472-9792(02)00083-5

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12758192